Search by Drug Name or NDC
NDC 57896-0739-04 GUAIASORB 20; 200 mg/10mL; mg/10mL Details
GUAIASORB 20; 200 mg/10mL; mg/10mL
GUAIASORB is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Geri-Care Pharmaceuticals, Corp. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 57896-0739-04Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 57896-0739-04Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 57896-0739 |
---|---|
Product ID | 57896-739_098692be-efb4-5175-e063-6394a90a1ac2 |
Associated GPIs | |
GCN Sequence Number | 000652 |
GCN Sequence Number Description | guaifenesin/dextromethorphan LIQUID 100-10MG/5 ORAL |
HIC3 | B3T |
HIC3 Description | NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION |
GCN | 53491 |
HICL Sequence Number | 000223 |
HICL Sequence Number Description | GUAIFENESIN/DEXTROMETHORPHAN HBR |
Brand/Generic | Generic |
Proprietary Name | GUAIASORB |
Proprietary Name Suffix | DM |
Non-Proprietary Name | Dextromethorphan HBr, Guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | ORAL |
Active Ingredient Strength | 20; 200 |
Active Ingredient Units | mg/10mL; mg/10mL |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | Geri-Care Pharmaceuticals, Corp |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH DRUG |
Application Number | M012 |
Listing Certified Through | 2024-12-31 |
Package
NDC 57896-0739-04 (57896073904)
NDC Package Code | 57896-739-04 |
---|---|
Billing NDC | 57896073904 |
Package | 118 mL in 1 BOTTLE (57896-739-04) |
Marketing Start Date | 2023-03-31 |
NDC Exclude Flag | N |
Pricing Information | N/A |